USP8 inhibition suppresses prostate tumorigenesis via promoting RICTOR degradation to inhibit mTORC2 signaling
Science Advances · 20.11.2026 · 12 (47)
DOI: 10.1126/sciadv.aeh0679 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 20.11.2026. Verfasst von Jingchao Wang und 11 weiteren Autor:innen. Die Arbeit nennt 84 Literaturangaben. Gefördert von: Beth Israel Deaconess Medical Center.
Abstract (Originalsprache)
RICTOR plays an essential role in regulating mechanistic target of rapamycin complex 2 (mTORC2) kinase activity, but it remains largely elusive how RICTOR is aberrantly activated in human prostate cancer (PrCa). Here, we identify RICTOR as a substrate of Cullin 3–based ubiquitin ligase adaptor SPOP, an important tumor suppressor in PrCa. SPOP deficiency or cancer-derived SPOP mutations disrupt SPOP-mediated degradation of RICTOR, thereby promoting PrCa progression. Furthermore, we identify USP8 as its upstream deubiquitinase, and inhibition of USP8 specifically suppresses RICTOR/mTORC2 activity without affecting mTORC1. As such, the USP8 inhibitor induces RICTOR degradation concomitant with marked tumor suppression in vivo. Hence, these findings reveal an SPOP-USP8-RICTOR regulatory circuit that underlies PrCa tumorigenesis and provides a rationale for targeting RICTOR via USP8 inhibition as a therapeutic strategy for patients with PrCa.
Förderung
- Beth Israel Deaconess Medical Center
Zitieren
APA
Wang, J., Huang, D., Liu, B., Jiang, W., Dang, F., Chen, L., Hou, T., Yan, P., Qi, Y., Inuzuka, H., Li, L., & Wei, W. (2026). USP8 inhibition suppresses prostate tumorigenesis via promoting RICTOR degradation to inhibit mTORC2 signaling. Science Advances, 12(47). https://doi.org/10.1126/sciadv.aeh0679
Vancouver
Wang J, Huang D, Liu B, Jiang W, Dang F, Chen L, et al. USP8 inhibition suppresses prostate tumorigenesis via promoting RICTOR degradation to inhibit mTORC2 signaling. Science Advances. 2026;12(47). doi:10.1126/sciadv.aeh0679
BibTeX
@article{Wang2026,
author = {Wang, Jingchao and Huang, Daoyuan and Liu, Bo and Jiang, Weiwei and Dang, Fabin and Chen, Li and Hou, Tao and Yan, Peiqiang and Qi, Yihang and Inuzuka, Hiroyuki and Li, Lei and Wei, Wenyi},
title = {USP8 inhibition suppresses prostate tumorigenesis via promoting RICTOR degradation to inhibit mTORC2 signaling},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {47},
doi = {10.1126/sciadv.aeh0679}
}
EUVIMED